메뉴 건너뛰기
Urology
Volumn 67, Issue 3, 2006, Pages 458-460
Prostate-Specific Antigen: Update 2006
Author keywords

[No Author keywords available]
Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;
EID: 33644768080     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.12.026     Document Type: Article
Times cited : (22)
References (12)
  • 1
    • 0019122410 scopus 로고
    • Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay
    • M. Kuriyama, M.C. Wang, L.D. Papsidero Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay Cancer Res 40 1980 4658 4662
    • (1980) Cancer Res , vol.40 , pp. 4658-4662
    • Kuriyama, M.1    Wang, M.C.2    Papsidero, L.D.3
  • 2
    • 0038497523 scopus 로고    scopus 로고
    • Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen
    • R.S. Punglia, A.V. D'Amico, W.J. Catalona Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen N Engl J Med 349 2003 335 342
    • (2003) N Engl J Med , vol.349 , pp. 335-342
    • Punglia, R.S.1    D'Amico, A.V.2    Catalona, W.J.3
  • 3
    • 2442715038 scopus 로고    scopus 로고
    • Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter
    • I.M. Thompson, D.K. Pauler, P.J. Goodman Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter N Engl J Med 350 2004 2239 2246
    • (2004) N Engl J Med , vol.350 , pp. 2239-2246
    • Thompson, I.M.1    Pauler, D.K.2    Goodman, P.J.3
  • 4
    • 21444447966 scopus 로고    scopus 로고
    • Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower
    • I.M. Thompson, D.P. Ankerst, C. Chi Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower JAMA 294 2005 66 70
    • (2005) JAMA , vol.294 , pp. 66-70
    • Thompson, I.M.1    Ankerst, D.P.2    Chi, C.3
  • 5
    • 4544254807 scopus 로고    scopus 로고
    • The prostate specific antigen era in the United States is over for prostate cancer: What happened in the last 20 years?
    • T.A. Stamey, M. Caldwell, J.E. McNeal The prostate specific antigen era in the United States is over for prostate cancer what happened in the last 20 years? J Urol 172 2004 1297 1301
    • (2004) J Urol , vol.172 , pp. 1297-1301
    • Stamey, T.A.1    Caldwell, M.2    McNeal, J.E.3
  • 6
    • 22344457189 scopus 로고    scopus 로고
    • Preoperative PSA and progression-free survival after radical prostatectomy for Stage T1c disease
    • J.A. Antenor, K.A. Roehl, S.E. Eggener Preoperative PSA and progression-free survival after radical prostatectomy for Stage T1c disease Urology 66 2005 156 160
    • (2005) Urology , vol.66 , pp. 156-160
    • Antenor, J.A.1    Roehl, K.A.2    Eggener, S.E.3
  • 7
    • 24944433092 scopus 로고    scopus 로고
    • The prostatic specific antigen era is alive and well: Prostatic specific antigen and biochemical progression following radical prostatectomy
    • S.J. Freedland, L.A. Mangold, P.C. Walsh The prostatic specific antigen era is alive and well prostatic specific antigen and biochemical progression following radical prostatectomy J Urol 174 2005 1276 1281
    • (2005) J Urol , vol.174 , pp. 1276-1281
    • Freedland, S.J.1    Mangold, L.A.2    Walsh, P.C.3
  • 8
    • 0026522840 scopus 로고
    • Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease
    • H.B. Carter, J.D. Pearson, E.J. Metter Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease JAMA 267 1992 2215 2220
    • (1992) JAMA , vol.267 , pp. 2215-2220
    • Carter, H.B.1    Pearson, J.D.2    Metter, E.J.3
  • 9
    • 3042727071 scopus 로고    scopus 로고
    • Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy
    • A.V. D'Amico, M.H. Chen, K.A. Roehl Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy N Engl J Med 351 2004 125 135
    • (2004) N Engl J Med , vol.351 , pp. 125-135
    • D'Amico, A.V.1    Chen, M.H.2    Roehl, K.A.3
  • 10
    • 22844433445 scopus 로고    scopus 로고
    • Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy
    • A.V. D'Amico, A.A. Renshaw, B. Sussman Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy JAMA 294 2005 440 447
    • (2005) JAMA , vol.294 , pp. 440-447
    • D'Amico, A.V.1    Renshaw, A.A.2    Sussman, B.3
  • 11
    • 0028138626 scopus 로고
    • The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy
    • J.G. Trapasso, J.B. deKernion, R.B. Smith The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy J Urol 152 1994 1821 1825
    • (1994) J Urol , vol.152 , pp. 1821-1825
    • Trapasso, J.G.1    Dekernion, J.B.2    Smith, R.B.3
  • 12
    • 22844434877 scopus 로고    scopus 로고
    • Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy
    • S.J. Freedland, E.B. Humphreys, L.A. Mangold Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy JAMA 294 2005 433 439
    • (2005) JAMA , vol.294 , pp. 433-439
    • Freedland, S.J.1    Humphreys, E.B.2    Mangold, L.A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.